首页> 外文OA文献 >A Population Approach to Characterize Interferon Beta‐1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis

【2h】

A Population Approach to Characterize Interferon Beta‐1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis

机译：一种人口方法，表征干扰素β-1B对患者复发多发性硬化症患者对比增强病变的影响

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
A Gulati; F Bagnato; P Villoslada; N Velez de Mendizabal;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A Population Approach to Characterize Interferon Beta‐1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis [J] . A Gulati, F Bagnato, P Villoslada CPT: Pharmacometrics & Systems Pharmacology . 2015,第5期

机译：表征干扰素β-1b对复发性多发性硬化症患者增强造影剂病变影响的人群方法
2. Higher expression of IL-12R beta 2 is associated with lower risk of relapse in relapsing-remitting multiple sclerosis patients on interferon-beta 1b therapy during 3-year follow-up [J] . Milosevic Emina, Dujmovic Irena, Markovic Milos, Journal of Neuroimmunology: Official Bulletin of the Research Committee on Neuroimmunology of the World Federation of Neurology . 2015,第Null期

机译：IL-12R beta 2的较高表达与3年随访期间接受干扰素beta 1b治疗的复发缓解型多发性硬化症患者的复发风险较低相关
3. Analysis of peginterferon beta-1a exposure and Gd-enhanced lesion or T2 lesion response in relapsing-remitting multiple sclerosis patients [J] . Hang Yaming, Hu Xiao, Zhang Jie, Journal of pharmacokinetics and pharmacodynamics . 2016,第4期

机译：复发性多发性硬化症患者中聚乙二醇干扰素β-1a暴露和Gd增强病变或T2病变反应的分析
4. Microstructural Modulations in the Hippocampus Allow to Characterizing Relapsing-Remitting Versus Primary Progressive Multiple Sclerosis [C] . Lorenza Brusini, Ilaria Boscolo Galazzo, Muge Akinci, International Workshop on Brain-Lesion;Medical Image Computing and Computer Assisted Intervention Conference . 2020

机译：海马中的微观结构调制允许表征复发 - 延长与初级进步多发性硬化
5. Cost-Effectiveness of Oral Agents in Relapsing-Remitting Multiple Sclerosis Compared to Interferon-Based Therapy in Saudi Arabia [D] . Alskaabi, May. 2017

机译：沙特阿拉伯口服药物在复发缓解型多发性硬化症中的成本效果与基于干扰素的疗法相比
6. A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis [O] . A Gulati, F Bagnato, P Villoslada, 2015

机译：表征干扰素β-1b对复发性多发性硬化症患者增强造影剂病变影响的人群方法
7. Blood levels of transforming growth factor-beta 1 (TGF-β1) are elevated in both relapsing remitting and chronic progressive multiple sclerosis (MS) patients and are further augmented by treatment with interferon-beta 1b (IFN-β1b) [O] . Nicoletti, F, Di Marco, R, Patti, F, 1998

机译：复发性和慢性进行性多发性硬化症（MS）患者的血液中转化生长因子-β1（TGF-β1）的血药浓度均升高，并通过干扰素-β1b（IFN-β1b）的治疗进一步升高

A Population Approach to Characterize Interferon Beta‐1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis

著录项

引文网络

相似文献

相关主题

期刊订阅